IMIST


Fragment-based drug design : (notice n° 28680)

000 -LEADER
fixed length control field 05828cam a2200733Ki 4500
001 - CONTROL NUMBER
control field ocn746854847
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20211202100619.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu---unuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 110816s2011 ne af ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency N$T
Language of cataloging eng
Transcribing agency N$T
Modifying agency BUF
-- UMC
-- SCB
-- E7B
-- OCLCQ
-- UKMGB
-- OCLCQ
-- YDXCP
-- OPELS
-- OCLCQ
-- OPELS
-- OCLCF
Description conventions rda
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 015705653
Source Uk
019 ## -
-- 709639496
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780123812759 (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0123812755 (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780123812742 (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0123812747 (electronic bk.)
029 1# - (OCLC)
-- AU@
-- 000046885105
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)746854847
Canceled/invalid control number (OCoLC)709639496
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number QP601
Item number .M49eb vol. 493
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 023000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 072000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 058170
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.19
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library TEFA
245 00 - TITLE STATEMENT
Title Fragment-based drug design :
Remainder of title tools, practical approaches, and examples /
Statement of responsibility, etc edited by Lawrence C. Kuo.
250 ## - EDITION STATEMENT
Edition statement 1st ed.
264 #1 -
-- Amsterdam ;
-- Boston, Mass. :
-- Academic Press.
264 #4 -
-- c2011.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (li, 591 pages, [16] pages of plates) :
Other physical details illustrations (some color)
336 ## - CONTENT TYPE
Content Type Term text
Content Type Code txt
Source rdacontent
337 ## - MEDIA TYPE
Media Type Term computer
Media Type Code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier Type Term online resource
Carrier Type Code cr
Source rdacarrier
347 ## -
-- data file
-- rda
380 ## -
-- Bibliography
490 1# - SERIES STATEMENT
Series statement Methods in enzymology ;
Volume number/sequential designation v. 493
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and indexes.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Designing a diverse high-quality library for crystallography-based FBDD screening -- Preparation of protein samples for NMR structure, function, and small-molecule screening studies -- Key factors for successful generation of protein-fragment structures requirement on protein, crystals, and technology -- Predicting the success of fragment screening by X-ray crystallography -- Fragment screening of stabilized G-protein-coupled receptors using biophysical methods -- Using computational techniques in fragment-based drug discovery -- How to avoid rediscovering the known -- From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance -- Practical aspects of NMR-based fragment screening -- Binding site identification and structure determination of protein-ligand complexes by NMR a semiautomated approach -- Protein thermal shifts to identify low molecular weight fragments -- HTS reporter displacement assay for fragment screening and fragment evolution toward leads with optimized binding kinetics, binding selectivity, and thermodynamic signature -- Fragment screening purely with protein crystallography -- Computational approach to de novo discovery of fragment binding for novel protein states -- Lead generation and examples opinion regarding how to follow up hits -- Medicinal chemistry inspired fragment-based drug discovery -- Effective progression of nuclear magnetic resonance-detected fragment hits -- Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy -- Electron density guided fragment-based drug design--a lead generation example -- Experiences in fragment-based lead discovery -- Fragment screening of infectious disease targets in a structural genomics environment.
588 ## -
-- Description based on print version record.
520 ## - SUMMARY, ETC.
Summary, etc There are numerous excellent reviews on Fragment Based Drug Discovery (FBDD), but there are to date no hand-holding guides or protocols with which one can embark on this orthogonal approach to complement traditional high throughput screening methodologies. This Methods in Enzymology volume offers the tools, practical approaches, and hit-to-lead examples on how to conduct FBDD screens. The chapters in this volume cover methods that have proven to be successful in generating leads from fragments, including chapters on how to apply computational techniques, nuclear magnetic resonance, surface plasma resonance, thermal shift and binding assays, protein crystallography, and medicinal chemistry in FBDD. Also elaborated by experienced researchers in FBDD are sample preparations of fragments, proteins, and GPCR as well as examples of how to generate leads from hits. Offers the tools, practical approaches, and hit-to-lead examples on how to conduct FBDD screens. The chapters in this volume cover methods that have proven to be successful in generating leads from fragments, including chapters on how to apply computational techniques, nuclear magnetic resonance, surface plasma resonance, thermal shift and binding assays, protein crystallography, and medicinal chemistry in FBDD.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Design.
9 (RLIN) 40331
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug development.
9 (RLIN) 40332
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Research.
9 (RLIN) 40333
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Drug Guides.
Source of heading or term bisacsh
9 (RLIN) 40334
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacology.
Source of heading or term bisacsh
9 (RLIN) 40335
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacy.
Source of heading or term bisacsh
9 (RLIN) 40336
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Nursing
-- Pharmacology.
Source of heading or term bisacsh
9 (RLIN) 40337
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug development.
Source of heading or term fast
-- (OCoLC)fst00898670
9 (RLIN) 40332
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Design.
Source of heading or term fast
-- (OCoLC)fst00898790
9 (RLIN) 40331
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Research.
Source of heading or term fast
-- (OCoLC)fst00898894
9 (RLIN) 40333
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
9 (RLIN) 20
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kuo, Lawrence C.
9 (RLIN) 40338
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Print version:
Title Fragment-based drug design.
Edition 1st ed.
Place, publisher, and date of publication Amsterdam ; Boston, Mass. : Academic Press, c2011
International Standard Book Number 9780123812742
Record control number (OCoLC)707096179
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Methods in enzymology ;
Volume number/sequential designation v. 493.
9 (RLIN) 26980
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://www.sciencedirect.com/science/book/9780123812742">http://www.sciencedirect.com/science/book/9780123812742</a>
938 ## -
-- ebrary
-- EBRY
-- ebr10483474
938 ## -
-- YBP Library Services
-- YANK
-- 6987015
938 ## -
-- EBSCOhost
-- EBSC
-- 376907
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Ebook
956 ## - LOCAL ELECTRONIC LOCATION AND ACCESS (OCLC)
Electronic name Consortium
994 ## -
-- C0
-- TEF

Pas d'exemplaire disponible.

© Tous droits résérvés IMIST/CNRST
Angle Av. Allal Al Fassi et Av. des FAR, Hay Ryad, BP 8027, 10102 Rabat, Maroc
Tél:(+212) 05 37.56.98.00
CNRST / IMIST

Propulsé par Koha